Genomics

Dataset Information

0

MicroRNA profiling of recurrent high grade ovarian carcinoma compared to primary ovarian cancer and normal ovary

ABSTRACT: To determine microRNA expression in chemoresistant ovarian cancer, we have employed whole microRNA microarray expression profiling as a discovery platform to identify genes with the potential to distinguish recurrent ovarian cancer. 8 recurrent ovarian cancer tissue and 8 primary ovarian cancer tissue and 4 normal ovarian tissue was used to identify miRNA profiling.

ORGANISM(S): Homo sapiens

PROVIDER: GSE83693 | GEO | 2017/06/01

SECONDARY ACCESSION(S): PRJNA326731

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics Gene expression and mutation profiles in HRR mutated recurrent ovarian cancers
2023-05-01 | GSE230541 | GEO
Transcriptomics RNAseq of primary and recurrent ovarian cancer tumors with and without BRCA1/2 mutations
2023-08-19 | GSE240829 | GEO
Methylation profiling WGBS of primary and recurrent ovarian cancer tumors with and without BRCA1/2 mutations
2022-07-31 | GSE202245 | GEO
Genomics microRNA profiling of ovarian cancer compared to normal ovary
2019-03-20 | GSE119055 | GEO
Transcriptomics Identification of drug associated genes in ovarian cancer by RNA profiling
2010-06-30 | E-GEOD-2058 | biostudies-arrayexpress
Genomics Whole genome characterisation of chemoresistant ovarian cancer
| PRJNA275136 | ENA
Genomics Analysis of Spatial Transcriptomics for Unveiling the novel molecular characteristics of Recurrent and Non-Recurrent High-Grade Serous Ovarian Cancer
| PRJNA1099922 | ENA
Genomics microRNA profiling of ovarian cancer compared to normal ovary
| PRJNA487948 | ENA
Transcriptomics Identification of drug associated genes in ovarian cancer by RNA profiling
2005-12-11 | GSE2058 | GEO
Transcriptomics Novel ABCG2 antagonists to reverse topotecan-mediated chemotherapeutic resistance in ovarian carcinoma xenografts.
2017-02-10 | GSE85582 | GEO